Former Ambassador Nancy Brinker, founder of Susan G. Komen, talks about the stigma that used to surround breast cancer and how she brought awareness to the disease.
Transcript
When you started the Susan G. Komen Foundation, there was a lot of stigma surrounding the subject of breast cancer. How did you bring the conversation about breast cancer into the open?
Well we really brought it out into the open because it was there, it was growing. People just didn't have the place to talk about it or share their feelings or share their insights or survival or their treatment—or their lack of survival. It was really waiting to happen. Because I had lost my only sister to the disease in 1980 and she asked me, I promised her that I would help cure breast cancer.
So, it's been a long ride, a long time, it's been almost 40 years of my life—she was diagnosed in 1978—and I realize that we had to do something, and it was going to require a movement. It wasn't just going to be a one [time] fundraiser, it was a movement. And of course, this pre-dated computers and cellphones and fax machines and everything else. We really only had telephones and each other to work with.
So, we named it Susan G. Komen in her honor—her memory—and set about working for many many years. We've managed to bring up the awareness, the sharing, and we've created a large community—a worldwide community—focused on breast cancer.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More